Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Brazilian regulator strengthens "economic protection" roles

This article was originally published in Clinica

Executive Summary

Brazil’s healthcare products regulatory agency Anvisa has signed a technical co-operation agreement with the national economic protection council (CADE), in an explicit move to strengthen Anvisa’s activities in the area of market competition. The move to broaden the agency’s core product quality and safety roles is notable too in that it is a further example of Anvisa’s stated intention to increasingly respond to the country’s industrial and supply interests (www.clinica.co.uk, 18 December 2012). The agreement builds on and formalises the relationship that both bodies already have with regard to Anvisa’s “market regulation” roles, said the agency. The joint activities that will be covered by the agreement include market research collaborations, information sharing, training programmes and “joint technical visits”.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT100146

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel